# Fasudil Eye Drop in Retinopathy Of Prematurity(ROP)

> **NCT04191954** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Shahid Beheshti University of Medical Sciences** · enrollment: 184 (estimated)

## Conditions studied

- Retinopathy of Prematurity

## Interventions

- **DRUG:** Fasudil eye drops (concentration 0.5 percent)
- **DRUG:** receive artificial tears drop

## Key facts

- **NCT ID:** NCT04191954
- **Lead sponsor:** Shahid Beheshti University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-06-02
- **Primary completion:** 2019-11-01
- **Final completion:** 2020-09
- **Target enrollment:** 184 (ESTIMATED)
- **Last updated:** 2019-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04191954

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04191954, "Fasudil Eye Drop in Retinopathy Of Prematurity(ROP)". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT04191954. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*